584
Views
3
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Validity of a Self-administered Questionnaire Version of the Transition Dyspnea Index in Patients with COPD

, , , , &
Pages 66-71 | Received 12 Jul 2016, Accepted 05 Oct 2016, Published online: 14 Nov 2016

ABSTRACT

The transition dyspnea index (TDI) is among the most widely used instruments in chronic obstructive pulmonary disease (COPD) patients to measure changes in dyspnea over time. In its original version it is used as guideline for a structured interview to assess the impact of daily activities on dyspnea in the three subdomains: functional impairment, magnitude of task, and magnitude of effort. However, the TDI is sometimes used as a self-administered paper-and-pencil questionnaire. The validity of this questionnaire format has not been tested, which was the aim of the present study. We tested 190 patients with COPD at start and end of a 3-week inpatient pulmonary rehabilitation program (PR). Dyspnea was assessed with the modified Medical Research Council Scale (mMRC), a questionnaire version of the TDI, and an interview version of the TDI. Group means for the TDI questionnaire and interview version were widely comparable for the TDI summary score and the three TDI subdomains. The scores of both TDI versions were strongly correlated and showed comparable, but only weak, correlations with changes during PR in spirometric lung function and mMRC. Improvement in dyspnea after PR was observed in 89% of patients when using the summary score of the questionnaire TDI, but only in 34% of patients when using the mMRC. The results suggest that a self-administered questionnaire format of the TDI is an adequate instrument for assessing changes in activity-related dyspnea during PR in patients with COPD. The responsiveness of this instrument to effects of PR appears greater than the responsiveness of the mMRC.

Introduction

Chronic obstructive pulmonary disease (COPD) is a prevalent and debilitating respiratory disease, characterized by persistent and usually progressive airflow limitation Citation(1,2). It is the third leading cause of mortality worldwide and associated with significant individual and socioeconomic burden Citation(1,3,4). Dyspnea is the highly aversive cardinal symptom of COPD and causes significant reductions in patients' activity levels and quality of life Citation(1,5,6). In fact, dyspnea is an important predictor of mortality in COPD with greater predictive value than spirometric lung function measures Citation(7,8). Consequently, reducing dyspnea is among the most important clinical outcomes in COPD Citation(1,9,10), requiring its routine monitoring, for example to evaluate treatment responses Citation(11–13).

In this regard, several instruments are available allowing patients to report the impact of daily activities on their dyspnea Citation(14). Specifically, the (modified) Medical Research Council scale (mMRC) Citation(15,16) and the transition dyspnea index (TDI) Citation(17) are among the most widely used instruments in clinical trials to assess changes in dyspnea with therapy Citation(18,19). Using the mMRC scale, the patient is asked to choose one of five grades that most closely matches daily activities (e.g., walking) that provoke dyspnea Citation(16). Potential limitations of the unidimensional mMRC are its exclusive dependence on individual activity levels and its limited response format. In order to overcome these limitations, Mahler and colleagues developed the multidimensional TDI (together with its companion baseline dyspnea index, BDI) to measure changes in dyspnea over time Citation(17). In its original version it is used as guideline for a structured interview to assess the impact of daily activities on dyspnea in the three subdomains of functional impairment, magnitude of task, and magnitude of effort. These dimensions are further condensed into a summary score Citation(17). The psychometric properties of the TDI have been established Citation(20–22) and it has been used widely in clinical trials evaluating various treatments in patients with COPD including pharmacotherapy Citation(23,24) and pulmonary rehabilitation (PR) Citation(25–28) with greater responsiveness to change than the MRC Citation(29,30). In addition, a self-administered computerized version of the TDI has been developed and validated, which showed comparable responsiveness to changes in dyspnea than the interviewer-administered version Citation(30,31). However, in clinical praxis the TDI is sometimes used as a self-administered paper-and-pencil questionnaire, which might represent a more economical alternative since it is independent of both interviewer and computer skills of respondents. To our knowledge, the validity of this TDI questionnaire format has yet not been tested.

Therefore, the primary aim of the present study was to test the validity of a self-administered paper-and-pencil format of the TDI for assessing changes in dyspnea in a large sample of patients with COPD undergoing a multidisciplinary PR program. Specifically, we tested the hypotheses that the TDI questionnaire version would 1) show comparable responsiveness than the TDI interview version and 2) demonstrate greater responsiveness to PR than the mMRC.

Materials and methods

Study design

This is a prospective, observational study in patients with COPD undergoing a multidisciplinary PR program. The primary outcome variables were dyspnea ratings using a TDI questionnaire and interview version, while secondary outcome variables included changes in mMRC dyspnea ratings and spirometric lung function measures.

Participants

We studied 190 consecutive patients with COPD who completed an established and standardized 3-week multidisciplinary inpatient PR at the Centre for Rehabilitation, Pneumology and Orthopedics (Clinic Bad Reichenhall, Germany) between May and November 2014. Anamnestic interviews and diagnostic classification were performed by pulmonary physicians according to Global initiative for chronic Obstructive Lung Disease (GOLD) criteria (1). Spirometry and body plethysmography was performed by specialized and trained diagnostic staff using a Masterlab 4.0 (Jaeger-Thoennies CareFusion, Hoechberg, Germany) according to American Thoracic Society (ATS)/European Respiratory Society (ERS) criteria Citation(32). Reference normal values for the forced expiratory volume in the first second (FEV1%pred) and the vital capacity (VC%pred) were taken from Quanjer et al. Citation(33). Inclusion criteria were 1) diagnosis of COPD according to GOLD criteria (1), 2) stable clinical condition, and 3) the ability to read and understand German. The following sociodemographic and clinical variables were collected for this study: age, gender, FEV1, VC, dyspnea (TDI, mMRC), COPD severity [based on GOLD criteria (1)], body mass index (BMI), exacerbations in preceding 12 months, 6-minute walking distance (6 MWD), chronic oxygen use, and smoking status. The study was approved by the local ethics committee (Bayerische Landesärztekammer, No. 12107) and all patients provided written informed consent.

mMRC scale

The patients read the German language version of the 5-point mMRC scale Citation(16), which was presented on a piece of paper, and circled the grade (0–4) that most closely matches the daily activities that provoke dyspnea. Higher scores represent more dyspnea.

Questionnaire TDI

The patients read the German language version of the TDI Citation(17), which was presented on a piece of paper. Compared to the interviewer administered version, the statements were slightly re-phrased into a first-person form (e.g., “I was formerly working and had to stop working […]” instead of “Formerly working and has had to stop working […]”). Patients were instructed to read these statements on changes in functional impairment attributed to dyspnea, magnitude of the task that produces dyspnea, and magnitude of effort exerted to produce dyspnea and to relate these changes to the time directly before PR. They circled the statement that most closely matched their perceived changes in dyspnea. Resultant scores ranged for each of the three dimensions from +3 (major improvement) to −3 (major deterioration), with an additional, non-scored response option (“Further impairment for reasons other than shortness of breath”).

Interview TDI

The patients were questioned individually by a trained interviewer (study assistant). The interviewer rated the change in dyspnea in the same three dimensions as the questionnaire TDI, again in relation to the time directly before PR and using the same response scores.

Procedure

At the start of PR, patients provided informed written consent, underwent anamnestic and diagnostic examinations, underwent spirometric lung function testing and filled out the mMRC. Thereafter, patients completed the routine 3-week multidisciplinary inpatient PR program. At the end of PR, all measurements were repeated. In addition, the pre-post PR change in activity-related dyspnea was assessed with the two versions of the TDI. In analogy to the validation studies of the self-administered computerized version of the TDI by Mahler et al. Citation(30,31), the questionnaire TDI was always completed first, followed by the interview TDI. This order avoided potentially biasing influences of the interview on the subsequent self-administered version, which have been reported earlier Citation(31).

Statistical analysis

Outcome measures are presented as mean (±SD). The scores for the three dimensions of the questionnaire TDI and interview TDI as well as the respective summary scores (range: −9 to +9) were calculated. Following the analyses strategy of Mahler et al. Citation(30,31), paired t-tests were used to compare the questionnaire and interview versions. Pearson correlation coefficients (two-tailed) were used as a measure of the goodness of fit, completed by calculating intraclass correlation coefficients (ICC) to indicate the absolute agreement between both TDI versions. A Bland–Altman plot was used to examine the relationship between the difference of the summary scores of the questionnaire TDI and interview TDI and the mean score of both TDI versions. In addition, the associations between the two TDI summary scores and changes in lung function (▵FEV1%pred, ▵VC%pred) and dyspnea (▵mMRC) from start to end of pulmonary rehabilitation were analyzed using Pearson correlation coefficients (two-tailed). Data were analyzed using SPSS 23 software (SPSS Inc., Chicago, IL) using a statistical significance threshold of α < 0.05.

Results

Baseline characteristics of the 190 patients (61 female patients, 129 male patients) are presented in . The majority of patients had moderate to severe levels of COPD according to GOLD criteria (1). As a group, the patients demonstrated moderate dyspnea during activities (mMRC = 2.60 ± 1.15) and moderate to severe impairment in lung function (FEV1%pred = 51.27 ± 14.79).

Table 1. Mean (SD) baseline characteristics of participants.

Mean (±SD) values for the questionnaire TDI and interview TDI as well as their correlations are presented in . Inspection of the group means for both TDI versions reveals that these were widely comparable for the summary score (4.3 vs. 4.5) () and for the subdomains functional impairment (1.2 vs. 1.4), magnitude of task (1.8 vs. 1.8), and magnitude of effort (1.3 vs. 1.3). However, t-tests indicated that the small difference of 0.2 units between both TDI versions was statistically significant for the summary score (t(189) = 2.90, p < 0.05) and the subdomain functional impairment (t(189) = 2.49, p < 0.01) with slightly lower scores for the questionnaire TDI. The Bland–Altman plot in shows that the majority of patients showed no difference in the summary scores between the questionnaire TDI and interview TDI.

Table 2. Means (SD) and correlations of questionnaire TDI and interview TDI.

Figure 1. Summary scores for questionnaire TDI and interview TDI.

Figure 1. Summary scores for questionnaire TDI and interview TDI.

Figure 2. Bland–Altman plot showing the difference between the questionnaire TDI and interview TDI summary scores against the mean of the questionnaire TDI and interview TDI summary scores. Overall, the majority of patients showed no difference in dyspnea estimates between the questionnaire and interview TDI version. The range of summary scores for the TDI is −9 (deterioration) to +9 (improvement). Solid line: mean value; dashed line: mean ± 1.96 SD of the scores.

Figure 2. Bland–Altman plot showing the difference between the questionnaire TDI and interview TDI summary scores against the mean of the questionnaire TDI and interview TDI summary scores. Overall, the majority of patients showed no difference in dyspnea estimates between the questionnaire and interview TDI version. The range of summary scores for the TDI is −9 (deterioration) to +9 (improvement). Solid line: mean value; dashed line: mean ± 1.96 SD of the scores.

The correlations between the TDI versions were very high and statistically significant for all scores (p's < 0.001) with a range from r = 0.73 (functional impairment) to r = 0.98 (magnitude of effort). Similarly, ICCs between the TDI versions were very high ranging from ICC = 0.84 (functional impairment) to ICC = 0.99 (magnitude of effort) (). Comparable correlations between the summary scores of both TDI versions and changes in lung function (▵FEV1%pred, ▵VC%pred) and dyspnea (▵mMRC) during PR were observed (). Although statistically significant, these correlations were only of weak magnitude (r's = 0.17 to −0.24).

Table 3. Correlations of TDI summary scores and changes in lung function and dyspnea from start to end of pulmonary rehabilitation.

Notably, the majority of patients (N = 169, 89%) experienced an improvement in dyspnea after PR as measured by the summary score of the questionnaire TDI, while only a minority of 12 patients (6%) reported no change. In contrast, only a minority of patients (N = 64, 34%) experienced an improvement in dyspnea after PR when measured with the mMRC, while the majority of patients (N = 108, 57%) reported no change. For these same 108 patients, the mean summary score of their questionnaire TDI was 3.7 (±3.4) (for the interview TDI: 4.0 ± 3.1), which is clearly above the minimal clinically important difference for the TDI of +1 unit Citation(20).

Discussion

The present study examined the validity of a self-administered paper-and-pencil format of the TDI for assessing changes in activity-related dyspnea in patients with COPD undergoing a multidisciplinary PR program. Specifically, we compared a TDI questionnaire version with a TDI interview version and further compared the questionnaire TDI with the mMRC regarding the responsiveness to PR. The major findings of this study in 190 patients with COPD are as follows: 1) the questionnaire TDI provides comparable estimates for changes in dyspnea during PR than the interview TDI; 2) both TDI versions show comparable, but weak associations with changes in lung function; and 3) the responsiveness of the questionnaire TDI to changes in dyspnea during PR is greater than that of the mMRC. Together, these results suggest that a self-administered paper-and-pencil format of the TDI might be an adequate instrument for assessing changes in dyspnea during PR in patients with COPD. This questionnaire format might be a more economical alternative to the interview format in cases where no interviewers are available, for example in postal surveys, and it is independent of computers and computer skills of respondents.

The present result converge with previous findings by Mahler and colleagues who compared a self-administered computerized version of the TDI with an interview version Citation(30,31). As in the present study, they merely observed a minimally lower mean value for the summary score of the self-administered computerized TDI version when compared to the interview version (1.4 vs. 1.8) Citation(30). Similarly, they reported high correlations between both TDI versions, which resemble those obtained in the present study Citation(30,31). Notably, the correlations (r = 0.94) between the TDI summary scores of the self-administered and interview versions are identical in the current study and in the study of Mahler et al. Citation(31).

In the present study, we observed comparable correlations between the summary scores of both TDI versions and changes in lung function during PR that, although statistically significant, were of rather weak size. This corresponds with several previous studies, which similarly reported only modest associations between dyspnea ratings and lung function measures in patients with COPD Citation(17,30,31,34–36). Together, these findings emphasize that dyspnea measures represent a different construct than the results of lung function testing and underscore the pivotal importance of routine assessments of dyspnea in patients Citation(11–13).

In this regard, differences exist in the responsiveness of different instruments used for the assessment of dyspnea Citation(14,29,37). For example, the present study revealed only weak correlations between the changes in the mMRC score during PR and the summary scores of both questionnaire TDI and interview TDI. This is in line with previous studies which also observed only modest correlations between TDI scores and changes in MRC scores after PR or pharmacotherapy, respectively Citation(29,30). Also in other patient-reported domains such as quality of life, only weak correlations between different instruments for the measurement of changes (e.g., prospective vs. retrospective instruments) have been reported Citation(38,39). Importantly, the choice of measurement instrument significantly impacts the evaluation of treatment success. In the present study, the majority of patients (89%) reported an improvement in dyspnea after PR when using the questionnaire TDI, whereas only a minority of patients (34%) reported an improvement in dyspnea when using the mMRC. In fact, the majority of patients (57%) reported no change in dyspnea based on their mMRC ratings, although the mean summary TDI scores of these very same patients were clearly above the minimal clinically important difference for this instrument, thus indicating a relevant improvement in dyspnea during PR. A similar disagreement between TDI scores and MRC scores after PR and pharmacotherapy was reported previously Citation(29,30). For example, in the study by Mahler and colleagues Citation(30) 55% of the patients reported no change in dyspnea using the MRC, whereas the mean TDI scores of the same patients indicated an improvement in dyspnea by reaching the minimal clinically important difference. Together, these findings underscore the limited responsiveness of the (m)MRC for measuring changes in dyspnea and for evaluating treatment response Citation(29,30,35).

Conclusion

The present findings suggest that a self-administered questionnaire format of the TDI is an adequate instrument for assessing changes in dyspnea during PR in patients with COPD. It provides comparable estimates for changes in activity-related dyspnea than the interviewer format with comparable, but weak associations with lung function measures. The responsiveness of this instrument to effects of PR appears greater than the responsiveness of the mMRC.

Acknowledgments

The authors wish to thank Sibylle Petersen, Eva Elisabeth Münch, and Berta Obermaier for their assistance during the data collection.

Funding

This work was supported by a grant from the Research Fund KU Leuven to AvL (STRT/13/002). The funding source was not involved: in the study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.

ORCID

Andreas von Leupoldt http://orcid.org/0000-0001-8539-8131

References

  • Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for Diagnosis, Management, and Prevention of COPD. 2016; Available from: http://www.goldcopd.com
  • Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, et al. International variation in the prevalence of COPD (the BOLD Study): A population-based prevalence study. Lancet 2007; 370(9589):741–750. DOI: 10.1016/S0140-6736(07)61377-4
  • Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380(9859):2095–2128. DOI: 10.1016/S0140-6736(12)61728-0
  • Menzin J, Boulanger L, Marton J, Guadagno L, Dastani H, Dirani R, et al. The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population. Respir Med 2008; 102(9):1248–1256. DOI: 10.1016/j.rmed.2008.04.009
  • O'Donnell DE, Banzett RB, Carrieri-Kohlman V, Casaburi R, Davenport PW, Gandevia SC, et al. Pathophysiology of dyspnea in chronic obstructive pulmonary disease: A roundtable. Proc Am Thorac Soc 2007; 4(2):145–168. DOI: 10.1513/pats.200611-159CC
  • Laviolette L, Laveneziana P, ERS Research Seminar Faculty. Dyspnoea: A multidimensional and multidisciplinary approach. Eur Respir J 2014; 43(6):1750–1762. DOI: 10.1183/09031936.00092613
  • Figarska SM, Boezen HM, Vonk JM. Dyspnea severity, changes in dyspnea status and mortality in the general population: The Vlagtwedde/Vlaardingen study. Eur J Epidemiol 2012; 27(11):867–876. DOI: 10.1007/s10654-012-9736-0
  • Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002; 121(5):1434–1440.
  • Cazzola M, MacNee W, Martinez FJ, Rabe KF, Franciosi LG, Barnes PJ, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J 2008; 31(2):416–469. DOI: 10.1183/09031936.00099306
  • Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013; 188(8):e13–64. DOI: 10.1164/rccm.201309-1634ST
  • Banzett RB, Schwartzstein RM. Dyspnea: Don't Just Look, Ask! Am J Respir Crit Care Med 2015; 192(12):1404–1406. DOI: 10.1164/rccm.201508-1637ED
  • Currow DC, Abernethy AP, Ko DN. The active identification and management of chronic refractory breathlessness is a human right. Thorax 2014; 69(4):393–394. DOI: 10.1136/thoraxjnl-2013-204701
  • Parshall MB, Schwartzstein RM, Adams L, Banzett RB, Manning HL, Bourbeau J, et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med 2012; 185(4):435–452. DOI: 10.1164/rccm.201111-2042ST
  • Parshall MB, Schwartzstein RM. Domains of dyspnea measurement. In: Mahler DA, O'Donnell DE, eds. Dyspnea: Mechanisms, measurement, and management, 3rd ed. Boca Raton: CRC Press; 2014:85–98.
  • Fletcher CM, Elmes PC, Fairbairn AS, Wood CH. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J 1959; 2(5147):257–2066.
  • Brooks S. American Thoracic Society (ATS) task group on surveillance for respiratory hazards in the occupational setting. Surveillance for respiratory hazards. ATS News 1982; 8:12–16.
  • Mahler DA, Weinberg DH, Wells CK, Feinstein AR. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984; 85(6):751–758.
  • Bausewein C, Farquhar M, Booth S, Gysels M, Higginson JJ. Measurement of breathlessness in advanced disease: a systematic review. Respir Med 2007; 101(3):399–410. DOI: 10.1016/j.rmed.2006.07.003
  • Oga T, Nishimura K. Longitudinal changes in dyspnea. In: Mahler DA, O'Donnell DE, eds. Dyspnea: Mechanisms, measurement, and management, 3rd ed. Boca Raton: CRC Press; 2014:99–109.
  • Mahler DA, Witek TJ. The MCID of the transition dyspnea index is a total score of one unit. COPD 2005; 2(1):99–103.
  • Witek TJ, Mahler DA. Meaningful effect size and patterns of response of the transition dyspnea index. J Clin Epidemiol 2003; 56(3):248–255.
  • Mahler DA, Ward J, Waterman LA, McCusker C, Zuwallack R, Baird JC. Patient-reported dyspnea in COPD reliability and association with stage of disease. Chest 2009; 136(6):1473–1479. DOI: 10.1378/chest.09-0934
  • Casaburi R, Mahler DA, Jones PW, Wanner A, San PG, ZuWallack RL, et al. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J 2002; 19(2):217–224.
  • Mahler DA, Wire P, Horstman D, Chang CN, Yates J, Fischer T, et al. Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166(8):1084–1091. DOI: 10.1164/rccm.2112055
  • Reardon J, Awad E, Normandin E, Vale F, Clark B, ZuWallack RL. The effect of comprehensive outpatient pulmonary rehabilitation on dyspnea. Chest 1994; 105(4):1046–1052.
  • Ries AL, Kaplan RM, Myers R, Prewitt LM. Maintenance after pulmonary rehabilitation in chronic lung disease: a randomized trial. Am J Respir Crit Care Med 2003; 167(6):880–888. DOI: 10.1164/rccm.200204-318OC
  • von Leupoldt A, Hahn E, Taube K, Schubert-Heukeshoven S, Magnussen H, Dahme B. Effects of 3-week outpatient pulmonary rehabilitation on exercise capacity, dyspnea, and quality of life in COPD. Lung 2008; 186(6):387–391. DOI: 10.1007/s00408-008-9089-3
  • von Leupoldt A, Taube K, Lehmann K, Fritzsche A, Magnussen H. The impact of anxiety and depression on outcomes of pulmonary rehabilitation in patients with COPD. Chest 2011; 140(3):730–736. DOI: 10.1378/chest.10-2917
  • de Torres JP, Pinto-Plata V, Ingenito E, Bagley P, Gray A, Berger R, et al. Power of outcome measurements to detect clinically significant changes in pulmonary rehabilitation of patients with COPD. Chest 2002; 121(4):1092–1098.
  • Mahler DA, Waterman LA, Ward J, McCusker C, ZuWallack R, Baird JC. Validity and responsiveness of the self-administered computerized versions of the baseline and transition dyspnea indexes. Chest 2007; 132(4):1283–1290. DOI: 10.1378/chest.07-0703
  • Mahler DA, Ward J, Fierro-Carrion G, WAterman LA, Lentine TF, Mejia-Alfaro R, et al. Development of self-administered versions of modified baseline and transition dyspnea indexes in COPD. COPD 2004; 1(2):165–172.
  • Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi A, Coates R, et al. Standardisation of spirometry. Eur Respir J 2005; 26(2):319–338. DOI: 10.1183/09031936.05.00034805
  • Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16:5–40.
  • Mahler DA, Harver A. A factor analysis of dyspnea ratings, respiratory muscle strength, and lung function in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1992; 145(2 Pt 1):467–470. DOI: 10.1164/ajrccm/145.2_Pt_1.467
  • Montes de Oca M, Tálamo C, Halbert RJ, Perez-Padilla R, Lopez MV, Mui‡ño A, et al. Health status perception and airflow obstruction in five Latin American cities: the PLATINO study. Respir Med 2009; 103(9):1376–1382. DOI: 10.1016/j.rmed.2009.03.005
  • Redelmeier DA, Goldstein RS, Min ST, Hyland RH. Spirometry and dyspnea in patients with COPD. When small differences mean little. Chest 1996; 109(5):1163–1168.
  • Perez T, Burgel PR, Paillasseur J-L, Caillaud D, Deslée G, Chanez P, et al. Modified medical research council scale vs baseline dyspnea index to evaluate dyspnea in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2015; 10:1663–1672. DOI: 10.2147/COPD.S82408
  • Nieuwkerk PT, Sprangers MA. Each measure of patient-reported change provides useful information and is susceptible to bias: the need to combine methods to assess their relative validity. Arthritis Rheum 2009; 61(12):1623–1625. DOI: 10.1002/art.25030
  • Blome C, Augustin M. Measuring change in quality of life: bias in prospective and retrospective evaluation. Value Health J Int Soc Pharmacoeconomics Outcomes Res 2015; 18(1):110–115. DOI: 10.1016/j.jval.2014.10.007

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.